TORCH Infections and Pregnancy Outcomes
Introduction to TORCH Infections
- The American College of Obstetricians and Gynecologists recommends that pregnant women with bad obstetric history, such as recurrent pregnancy loss or previous congenital malformations, should be screened for TORCH infections, which include Toxoplasmosis, Other agents, Rubella, Cytomegalovirus (CMV), and Herpes simplex virus (HSV) 1
Diagnostic Approach
- The Centers for Disease Control and Prevention (CDC) suggests that amniocentesis with PCR for CMV DNA is the best diagnostic test for CMV infection, most sensitive when performed after 21 weeks gestation and >6 weeks from maternal infection 1
- The American Academy of Family Physicians recommends testing for IgM and IgG antibodies by ELISA or chemiluminescence immunoassay to distinguish acute from past infection, with IgM positive indicating acute/recent infection and IgG positive alone indicating past infection 3
Management and Prevention
- The American College of Obstetricians and Gynecologists recommends that all women of reproductive age should receive preconception counseling about TORCH prevention, including rubella vaccination for seronegative women before pregnancy and avoiding exposure to toxoplasmosis through proper food handling and cat litter avoidance 3
- The CDC recommends using latex condoms to reduce HSV transmission risk and insect repellent and protective clothing in areas with vector-borne disease transmission 5, 7
Treatment and Outcomes
- The American Academy of Pediatrics recommends that early treatment of toxoplasmosis reduces transmission by 52% but requires prompt initiation within 3 weeks of seroconversion, and that ganciclovir or valganciclovir may be considered for CMV infection but are pregnancy category C with limited safety data 2, 8
- The CDC reports that congenital malformations occur in 12.9% of TORCH-infected pregnancies, significantly higher than the 1.1% rate in uninfected pregnancies, and that among infected women, 70-90% of infected newborns are asymptomatic at birth but may develop late sequelae including chorioretinitis, hearing loss, and developmental delays 2